Growth Metrics

Ardelyx (ARDX) Cash from Operations (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Ardelyx 1.48 Bn 1.25 Bn 89.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -253.87%
Dec 31, 2025 5,640.00%
Sep 30, 2025 101.44%
Jun 30, 2025 34.10%
Mar 31, 2025 -492.02%
Dec 31, 2024 1,858.08%
Sep 30, 2024 102.58%
Jun 30, 2024 45.70%
Mar 31, 2024 -309.75%
Dec 31, 2023 59.39%
Sep 30, 2023 -45.67%
Jun 30, 2023 67.10%
Mar 31, 2023 -413.60%
Dec 31, 2022 156.18%
Sep 30, 2022 18.71%
Jun 30, 2022 -13.25%
Mar 31, 2022 30.02%
Dec 31, 2021 -14.11%
Sep 30, 2021 -0.91%
Jun 30, 2021 22.48%
Mar 31, 2021 -151.38%
Dec 31, 2020 11.51%
Sep 30, 2020 -4.49%
Jun 30, 2020 23.75%
Mar 31, 2020 -123.99%
Dec 31, 2019 45.97%
Sep 30, 2019 25.90%
Jun 30, 2019 -64.49%
Mar 31, 2019 8.26%
Dec 31, 2018 31.77%
Sep 30, 2018 -49.98%
Jun 30, 2018 -164.77%
Mar 31, 2018 -244.83%
Dec 31, 2017 124.42%
Sep 30, 2017 19.45%
Jun 30, 2017 10.74%
Mar 31, 2017 -0.05%
Dec 31, 2016 -8.57%
Sep 30, 2016 1.06%
Jun 30, 2016 -53.27%
Mar 31, 2016 24.79%
Dec 31, 2015 -83.01%
Sep 30, 2015 60.94%
Jun 30, 2015 -268.18%
Mar 31, 2015 -116.48%
Dec 31, 2014 33.30%
Sep 30, 2014 -123.69%
Jun 30, 2014 2,242.32%
Mar 31, 2014 -110.27%
Dec 31, 2013 5,580.90%